Novel de novo SHANK3 mutation in autistic patients

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

• Publication date

  2009-04-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ajmg.b.30822PMID 18615476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of SHANK3 mutations to autism spectrum disorder.

  2007cited by this paper
• Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

  2007influential reference
• NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population

  2005cited by this paper
• The genetics of autism.

  2004cited by this paper
• Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

  2003cited by this paper
• Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism

  2003cited by this paper
• The genetics of autism

  2001cited by this paper
• Neuropathology of infantile autism

  1998cited by this paper
• Neuropathology of infantile autism.

  1998cited by this paper
• Hippocampus in autism: a Golgi analysis

  1995cited by this paper

• Insertion of rare autism variants in synaptic genes induce novel behavioral phenotypes in C. elegans

  2025cites this paper
• Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer’s disease

  2025cites this paper
• Small SNPs, Big Effects: A Review of Single Nucleotide Variations and Polymorphisms in Key Genes Associated With Autism Spectrum Disorder

  2025cites this paper
• Developmental CA2 perineuronal net reduction restores social memory in Shank3 mutant mice

  2025cites this paper
• Alternative splicing in autism spectrum disorder: Recent insights from mechanisms to therapy.

  2025cites this paper
• Rodent Models for ASD Biomarker Development.

  2024cites this paper
• Deciphering the Role of Shank3 in Dendritic Morphology and Synaptic Function Across Postnatal Developmental Stages in the Shank3B KO Mouse

  2024cites this paper
• Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan–McDermid Syndrome

  2024cites this paper
• Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved

  2024cites this paper
• Epigenetic Insights into Autism Spectrum Disorder: DNA Methylation Levels of NR3C1, ASCL1, and FOXO3 in Korean Autism Spectrum Disorder Sibling Pairs

  2024cites this paper
• Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome

  2024cites this paper
• Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.

  2024cites this paper
• Key Synaptic Pathology in Autism Spectrum Disorder: Genetic Mechanisms and Recent Advances.

  2024cites this paper
• Sex-specific modulation of safety learning in Shank2-deficient mice.

  2024cites this paper
• Autism-associated gene shank3 is necessary for social contagion in zebrafish

  2023cites this paper
• Adolescent sleep defects and dopaminergic hyperactivity in mice with a schizophrenia-linked Shank3 mutation.

  2023cites this paper
• The Shank/ProSAP N-Terminal (SPN) Domain of Shank3 Regulates Targeting to Postsynaptic Sites and Postsynaptic Signaling

  2023cites this paper
• A Critical Review of the Impact of Candidate Copy Number Variants on Autism Spectrum Disorder.

  2023cites this paper
• Reduced neurite density index in the prefrontal cortex of adults with autism assessed using neurite orientation dispersion and density imaging

  2023cites this paper
• Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics

  2023cites this paper
• ASD-associated gene: SHANK3

  2023cites this paper
• Updated consensus guidelines on the management of Phelan–McDermid syndrome

  2023cites this paper
• Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome

  2023cites this paper
• Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review

  2023cites this paper
• Shank3 deficits in the anteromedial bed nucleus of the stria terminalis trigger an anxiety phenotype in mice

  2023cites this paper
• Synaptic genes and neurodevelopmental disorders: From molecular mechanisms to developmental strategies of behavioral testing.

  2022cites this paper
• Shank postsynaptic scaffolding proteins in autism spectrum disorder: mouse models and their dysfunctions in behaviors, synapses, and molecules.

  2022cites this paper
• Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission

  2022cites this paper
• The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models

  2022cites this paper
• Age, brain region, and gene dosage-differential transcriptomic changes in Shank3-mutant mice

  2022cites this paper
• Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals

  2022cites this paper
• Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders

  2022cites this paper
• Prefrontal Circuits guiding Social Preference: Implications in Autism Spectrum Disorder.

  2022cites this paper
• Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future

  2022cites this paper
• Absence of familiarity triggers hallmarks of autism in mouse model through aberrant tail-of-striatum and prelimbic cortex signaling.

  2022cites this paper
• Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans

  2022cites this paper
• Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications

  2021cites this paper
• Posttranslational modifications & lithium's therapeutic effect - potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.

  2021cites this paper
• Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries

  2021cites this paper
• Optogenetic stimulation of BLA terminals in the BNST elicits long term synaptic plasticity and restores synaptic alterations induced by adolescent Shank3 downregulation

  2021cites this paper
• Interneuron development and dysfunction

  2021cites this paper
• Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders

  2021cites this paper
• Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses

  2021cites this paper
• The Development of the Mesoprefrontal Dopaminergic System in Health and Disease

  2021cites this paper
• DELETION 22q13 SYNDROME

  2021cites this paper
• Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders

  2021cites this paper
• Dendritic Integration Dysfunction in Neurodevelopmental Disorders

  2021cites this paper
• Neurodevelopmental malformations of the cerebellum and neocortex in the Shank3 and Cntnap2 mouse models of autism.

  2021cites this paper
• Case Report: Lennox–Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant

  2021cites this paper
• Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome

  2021cites this paper
• Social Deficits and Repetitive Behaviors Are Improved by Early Postnatal Low-Dose VPA Intervention in a Novel shank3-Deficient Zebrafish Model

  2021cites this paper
• Genetic influences of autism candidate genes on circuit wiring and olfactory decoding

  2021cites this paper
• Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder

  2020cites this paper
• Investigating the influence of perinatal nicotine and alcohol exposure on the genetic profiles of dopaminergic neurons in the VTA using miRNA–mRNA analysis

  2020cites this paper
• Perinatal Exposure to Diesel Exhaust-Origin Secondary Organic Aerosol Induces Autism-Like Behavior in Rats

  2020cites this paper
• Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies

  2020cites this paper
• Increased rates of cerebral protein synthesis in Shank3 knockout mice: Implications for a link between synaptic protein deficit and dysregulated protein synthesis in autism spectrum disorder/intellectual disability.

  2020influential citation
• SHANK3 Gene

  2020cites this paper
• Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus

  2020cites this paper
• Mechanistic Insights into the Interactions of Ras Subfamily GTPases with the SPN Domain of Autism‐associated SHANK3 †

  2020cites this paper
• Postnatal therapeutic approaches in genetic neurodevelopmental disorders

  2020cites this paper
• The specific role of zinc in autism spectrum disorders

  2020cites this paper
• CaMKIIα-driven, phosphatase-checked postsynaptic plasticity via phase separation

  2020cites this paper
• Uncovering the Functional Link Between SHANK3 Deletions and Deficiency in Neurodevelopment Using iPSC-Derived Human Neurons

  2019cites this paper
• Advances in the understanding of cellular pathogenesis associated with Autism Spectrum Disorder

  2019cites this paper
• Shank3 Binds to and Stabilizes the Active Form of Rap1 and HRas GTPases via Its NTD-ANK Tandem with Distinct Mechanisms.

  2019cites this paper
• Characteristics of the effects of genetic variation in rodent models of risk for schizophrenia and neurodevelopment disorder

  2019cites this paper
• SHANK1 polymorphisms and SNP–SNP interactions among SHANK family: A possible cue for recognition to autism spectrum disorder in infant age

  2019cites this paper
• Molecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3

  2019cites this paper
• Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice

  2019cites this paper
• Enhanced Glutamatergic Currents at Birth in Shank3 KO Mice

  2019cites this paper
• An integrated transcriptomic analysis of autism spectrum disorder

  2019cites this paper
• Generation of mouse models of neurodevelopmental disorders using the CRISPR/Cas9 system

  2019influential citation
• Mouse models as a tool for discovering new neurological diseases.

  2019cites this paper
• Juvenile Shank3b deficient mice present with behavioral phenotype relevant to autism spectrum disorder

  2019cites this paper
• Epigenetic Regulations in Neuropsychiatric Disorders

  2019cites this paper
• Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing

  2019cites this paper
• The role of GABAergic signalling in altered sensory processing in ASD

  2018cites this paper
• Application of Human‐Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders

  2018cites this paper
• Association between SHANK3 polymorphisms and susceptibility to autism spectrum disorder.

  2018cites this paper
• SHANK 3 haploinsufficiency : a ” common ” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders

  2018cites this paper
• Association analysis of two synapse-related gene mutations with autism spectrum disorder in a Chinese population

  2018cites this paper
• Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1

  2018influential citation
• mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders.

  2018cites this paper
• Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders

  2018cites this paper
• Solution structures of the SH3 domains from Shank scaffold proteins and their interactions with Cav1.3 calcium channels

  2018cites this paper
• Polymorphisms of Shank 3 gene in Chinese Han Children with Autism Spectrum Disorders ( ASD ) : A case-control study

  2018cites this paper
• Functional Relevance of Missense Mutations Affecting the N-Terminal Part of Shank3 Found in Autistic Patients

  2018cites this paper
• Arid1b and Macf1 in Murine Brain Development and Behavior

  2018cites this paper
• Sam domains in multiple diseases.

  2018cites this paper
• Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations

  2018cites this paper
• Stem Cells to Inform the Neurobiology of Mental Illness.

  2018cites this paper
• The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder

  2018cites this paper
• USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels

  2018cites this paper
• Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function

  2018cites this paper
• Developmental social communication deficits in the Shank3 rat model of phelan‐mcdermid syndrome and autism spectrum disorder

  2018cites this paper
• Prospects of Zinc Supplementation in Autism Spectrum Disorders and Shankopathies Such as Phelan McDermid Syndrome

  2018cites this paper
• Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders.

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• SHANK3 variant as a cause of nonsyndromal autism in an 11-year-old boy and a review of published literature

  2018cites this paper